Effects of new beta-blocking agent (DL-tiprenolol) on conduction within normal and anomalous atrioventricular pathways in Wolff-Parkinson-White syndrome.
D000293:Adolescent; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000605:Amino Alcohols / Q000627:therapeutic use*; D001285:Atropine / Q000627:therapeutic use; D004562:Electrocardiography; D005260:Female; D006329:Heart Conduction System / Q000187:drug effects* / Q000503:physiopathology; D006339:Heart Rate; D006801:Humans; D008297:Male; D010138:Pacemaker, Artificial; D011437:Propylamines / Q000627:therapeutic use; D013440:Sulfides / Q000627:therapeutic use; D014927:Wolff-Parkinson-White Syndrome / Q000188:drug therapy* / Q000503:physiopathology / Q000628:therapy
D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D011437:Propylamines; D013440:Sulfides; D001285:Atropine